Sort   by:  
 Page size 
UnknownBeyond EGFR and ALK: targeting rare mutations in advanced non-small cell lung cancer.
Not available
S-EPMC5952024 | biostudies-literature
UnknownNon-small cell lung cancer (NSCLC) and central nervous system (CNS) metastases: role of tyrosine kinase inhibitors (TKIs) and evidence in favor or against their use with concurrent cranial radiotherapy.
Not available
S-EPMC5233883 | biostudies-literature
UnknownNeoadjuvant, Adjuvant and Perioperative Treatment in Early-Stage Non-Small Cell Lung Cancer (NSCLC) with Actionable Genomic Alterations: Current Landscape and Future Perspectives.
Not available
S-EPMC12897308 | biostudies-literature
UnknownFuture perspectives in cancer immunotherapy.
Not available
S-EPMC4971381 | biostudies-literature
UnknownImmunotherapy in non-small cell lung cancer: the clinical impact of immune response and targeting.
Not available
S-EPMC4971380 | biostudies-literature
UnknownManagement of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update.
Not available
S-EPMC6482353 | biostudies-literature
UnknownResistance to TKIs in EGFR-Mutated Non-Small Cell Lung Cancer: From Mechanisms to New Therapeutic Strategies.
Not available
S-EPMC9320011 | biostudies-literature
UnknownReal-world treatment patterns in patients with non-metastatic non-small cell lung cancer in Greece: the 'EVIDENCE' study.
Not available
S-EPMC11812321 | biostudies-literature
UnknownRole of mesenchymal-epithelial transition amplification in resistance to anti-epidermal growth factor receptor agents.
Not available
S-EPMC4416951 | biostudies-literature
UnknownNovel approaches for concurrent irradiation in locally advanced cervical cancer: platinum combinations, non-platinum-containing regimens, and molecular targeted agents.
Not available
S-EPMC3674741 | biostudies-literature
Sort   by:  
 Page size